Pancreatic Cancer Research

ResearcherUniversity of HoustonNo recent work listed

Chin‐Yo Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4461-6216; OpenAlex author ID A5028835404. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers

Papers 4

  1. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity. Last author DOI 10.1021/acschembio.0c00546↗
  2. Novel Liver X Receptor Ligand GAC0001E5 Disrupts Glutamine Metabolism and Induces Oxidative Stress in Pancreatic Cancer Cells. Last author DOI 10.3390/ijms21249622↗
  3. Clinical candidate and genistein analogue AXP107-11 has chemoenhancing functions in pancreatic adenocarcinoma through G protein-coupled estrogen receptor signa… Co-author DOI 10.1002/cam4.2581↗
  4. Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells. Last author DOI 10.1371/journal.pone.0106289↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shivangi Srivastava · 2 shared papers, 2020 · strength 0.22
  2. Husna Karaboga · 2 shared papers, 2014–2020 · strength 0.13
  3. Fahmi Mesmar · 1 shared paper, 2019 · strength 0.08
  4. Cecilia Williams · 1 shared paper, 2019 · strength 0.08
  5. Ya’an Kang · 1 shared paper, 2019 · strength 0.08
  6. Bingbing Dai · 1 shared paper, 2019 · strength 0.08
  7. Jason B. Fleming · 1 shared paper, 2019 · strength 0.08
  8. Michael P. Kim · 1 shared paper, 2019 · strength 0.08
  9. William E. Fisher · 1 shared paper, 2014 · strength 0.03
  10. Nicholes R. Candelaria · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.